Llwytho...
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. Since the discovery of KSHV 20 years ago, there is still no standard treatment and the management of virus-associated malignancies remains toxic...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Viruses |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4246246/ https://ncbi.nlm.nih.gov/pubmed/25421895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v6114731 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|